Patents by Inventor Fajie LI

Fajie LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF
    Publication number: 20230106958
    Abstract: The present invention discloses a receptor inhibitor of formula (I), a pharmaceutical composition comprising the same and the use thereof.
    Type: Application
    Filed: May 25, 2022
    Publication date: April 6, 2023
    Inventors: Yanping ZHAO, Hongjun WANG, Yeming WANG, Xiang LI, Yuanyuan JIANG, Huai HUANG, Fajie LI, Liying ZHOU, Ning SHAO, Fengping XIAO, Zhenguang ZOU
  • RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF
    Publication number: 20230030115
    Abstract: The present invention relates to a Rho-associated protein kinase inhibitor of formula (I), a pharmaceutical composition comprising the same, a preparation method thereof, and a use of the same in preventing or treating a disease mediated by Rho-associated protein kinase (ROCK).
    Type: Application
    Filed: July 6, 2021
    Publication date: February 2, 2023
    Inventors: Yanping ZHAO, Hongjun WANG, Gong LI, Yuanyuan JIANG, Xiang LI, Bin LIU, Weiting ZHONG, Kai LIU, Fajie LI, Liying ZHOU, Yanan LIU
  • Receptor inhibitor, pharmaceutical composition comprising same, and use thereof
    Patent number: 11453690
    Abstract: The present invention discloses a receptor inhibitor of formula (I), a pharmaceutical composition comprising the same and the use thereof.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: September 27, 2022
    Assignee: BEIJING TIDE PHARMACEUTICAL CO., LTD.
    Inventors: Yanping Zhao, Hongjun Wang, Yeming Wang, Xiang Li, Yuanyuan Jiang, Huai Huang, Fajie Li, Liying Zhou, Ning Shao, Fengping Xiao, Zhenguang Zou
  • Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof
    Patent number: 11390609
    Abstract: The present invention relates to a Rho-associated protein kinase inhibitor of formula (I), a pharmaceutical composition comprising the same, a preparation method thereof, and a use of the same in preventing or treating a disease mediated by Rho-associated protein kinase (ROCK).
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: July 19, 2022
    Assignee: BEIJING TIDE PHARMACEUTICAL CO., LTD.
    Inventors: Yanping Zhao, Hongjun Wang, Gong Li, Yuanyuan Jiang, Xiang Li, Bin Liu, Weiting Zhong, Kai Liu, Fajie Li, Liying Zhou, Yanan Liu
  • RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF
    Publication number: 20220002266
    Abstract: A Rho-associated protein kinase (ROCK) inhibitor represented by formula (I), a pharmaceutical composition comprising same, and a use thereof for preventing or treating ROCK-mediated diseases.
    Type: Application
    Filed: November 8, 2019
    Publication date: January 6, 2022
    Inventors: Yanping ZHAO, Hongjun WANG, Gong LI, Yuanyuan JIANG, Xiang LI, Bin LIU, Kai LIU, Weiting ZHONG, Fajie LI, Jing ZHAO, Jianmei PANG, Liying ZHOU
  • Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof
    Patent number: 11130749
    Abstract: The present invention relates to a Rho-associated protein kinase inhibitor of formula (I), a pharmaceutical composition comprising the same, a preparation method thereof, and a use of the same in preventing or treating a disease mediated by Rho-associated protein kinase (ROCK).
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: September 28, 2021
    Assignee: BEIJING TIDE PHARMACEUTICAL CO., LTD.
    Inventors: Yanping Zhao, Hongjun Wang, Gong Li, Yuanyuan Jiang, Xiang Li, Bin Liu, Weiting Zhong, Kai Liu, Fajie Li, Liying Zhou, Yanan Liu
  • RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF
    Publication number: 20210054007
    Abstract: The present invention discloses a receptor inhibitor of formula (I), a pharmaceutical composition comprising the same and the use thereof.
    Type: Application
    Filed: March 22, 2019
    Publication date: February 25, 2021
    Inventors: Yanping ZHAO, Hongjun WANG, Yeming WANG, Xiang LI, Yuanyuan JIANG, Huai HUANG, Fajie LI, Liying ZHOU, Ning SHAO, Fengping XIAO, Zhenguang ZOU
  • RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF
    Publication number: 20190276440
    Abstract: The present invention relates to a Rho-associated protein kinase inhibitor of formula (I), a pharmaceutical composition comprising the same, a preparation method thereof, and a use of the same in preventing or treating a disease mediated by Rho-associated protein kinase (ROCK).
    Type: Application
    Filed: June 29, 2018
    Publication date: September 12, 2019
    Applicant: BEIJING TIDE PHARMACEUTICAL CO., LTD.
    Inventors: Yanping ZHAO, Hongjun WANG, Gong LI, Yuanyuan JIANG, Xiang LI, Bin LIU, Weiting ZHONG, Kai LIU, Fajie LI, Liying ZHOU, Yanan LIU